Home TARIS Biomedical

TARIS Biomedical

acquired
Series B
Developer of drugs for bladder disease treatment
Basic
Enterprise Profile

Basic Information

TARIS Biomedical is building a unique urology company focused on therapeutics, developing targeted new treatments for millions of patients suffering from difficult-to-treat bladder conditions. We are advancing treatments for debilitating diseases, including bladder cancer and overactive bladder, by delivering continuous localized therapy where needed.
TARIS BIOMEDICAL LLC.
Massachusetts,United States of America
15~50 people
January 01, 2008
info@TARISbio.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Concept
Urology Department Tumor Therapeutic Products
Application Scenarios
Innovative Drugs